The DFCI PSOC is committed to disseminate current and newly generated knowledge of the evolution, diagnosis and treatment of cancer as well as physical sciences approaches to cancer research. This is the basis for our educational outreach and training initiatives designed to enhance the Center and integrate divergent fields. Scientific experts and seasoned mentors will offer a rich program intended to enhance the interaction and training of physicians and scientists both regionally and at off-site facilities from regularly scheduled seminars to specific working groups. We have designed targeted programs and individualized mentorship for faculty, postdocs, graduate and undergraduate students with an evaluation and enhancement process. Our PSOC Administrator has a dual role as the Educational and Outreach Director and is committed to reassessing the effectiveness of all educational programs offered. The Administrator and PIs will meet on a weekly basis to ensure that goals are being met. As part of our education and training program, we will offer an extensive postdoctoral training program, a graduate course at Harvard University on ?Mathematical Modeling of Cancer?, participation in the Harvard Stem Cell Institute summer internship program, a Junior Investigator Symposium, a seminar series, an annual meeting, two small retreats yearly for our PSOC members, and additional research training opportunities relevant to the PSOC research community. In addition, we have created a comprehensive outreach program targeting diverse populations such as patients, high school students, and the general public. We will offer community lectures, a Research on the Road program, social media campaign, participation in DFCI outreach initiatives, patient lecture series, and host a Women of Science conference. The expected result of our initiatives is the enhancement of professional knowledge with the immediate goal of stimulating new research ideas and outcomes that integrate back into the PSOC framework.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-TCRB-5 (J1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dana-Farber Cancer Institute
United States
Zip Code
Ozawa, Tatsuya; Arora, Sonali; Szulzewsky, Frank et al. (2018) A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-?B. Cell Rep 23:3787-3797
Cimino, Patrick J; Kim, Youngmi; Wu, Hua-Jun et al. (2018) Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in IDH wild-type glioblastoma. Genes Dev 32:512-523
Stein, Shayna; Zhao, Rui; Haeno, Hiroshi et al. (2018) Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients. PLoS Comput Biol 14:e1005924
Hinohara, Kunihiko; Wu, Hua-Jun; Vigneau, S├ębastien et al. (2018) KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance. Cancer Cell 34:939-953.e9
Mishima, Yuji; Paiva, Bruno; Shi, Jiantao et al. (2017) The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma. Cell Rep 19:218-224
Yu, H A; Sima, C; Feldman, D et al. (2017) Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers. Ann Oncol 28:278-284
Gibson, Christopher J; Lindsley, R Coleman; Tchekmedyian, Vatche et al. (2017) Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. J Clin Oncol 35:1598-1605
Wang, Nayi; Cheng, Jijun; Fan, Rong et al. (2017) Capture, amplification, and global profiling of microRNAs from low quantities of whole cell lysate. Analyst 142:3203-3211
Zhao, Rui; Catalano, Paul; DeGruttola, Victor G et al. (2017) Estimating mono- and bi-phasic regression parameters using a mixture piecewise linear Bayesian hierarchical model. PLoS One 12:e0180756
Jayatilaka, Hasini; Tyle, Pranay; Chen, Jonathan J et al. (2017) Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration. Nat Commun 8:15584

Showing the most recent 10 out of 36 publications